Editorial
The promise of stereotactic body radiotherapy—next phase of integration into oncological practice
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S8
.
(11 September 2017)
Review Article
The optimism surrounding stereotactic body radiation therapy and immunomodulation
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S9
.
(11 September 2017)
Stereotactic body radiation therapy for prostate cancer—a review
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S10
.
(11 September 2017)
Challenges in imaging assessment following liver stereotactic body radiotherapy: pitfalls to avoid in clinical practice
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S11
.
(11 September 2017)
Emerging technologies in stereotactic body radiotherapy
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S12
.
(11 September 2017)
Advances in external beam stereotactic body radiotherapy: principle concerns in implementing a liver radiation program
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S13
.
(11 September 2017)
Stereotactic radiosurgery of the brain: a review of common indications
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S14
.
(11 September 2017)
Re-irradiation with stereotactic body radiation therapy (SBRT)
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S15
.
(11 September 2017)
Stereotactic radiotherapy in oligometastatic cancer
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S16
.
(11 September 2017)
Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S17
.
(11 September 2017)
Postoperative stereotactic body radiotherapy for spinal metastases
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S18
.
(11 September 2017)
Exploiting molecular genomics in precision radiation oncology: a marriage of biological and physical precision
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S19
.
(11 September 2017)
Stereotactic body radiotherapy for early stage lung cancer—historical developments and future strategies
Chinese Clinical Oncology
2017;
6
(Suppl 2)
:S20
.
(11 September 2017)
Disclosure:
The focused issue “Advances in Stereotactic Radio Surgery” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Kevin L. M. Chua, David B. H. Tan, Melvin. L. K. Chua and Simon S. Lo served as the unpaid Guest Editors for the focused issue.
